References
- World Health Organization. Global tuberculosis control. Surveillance, planning, financing. WHO Report 2007. WHO/HTM/TB/2007.376. World Health Organization, Geneva, Switzerland, 1–242 (2007).
- World Health Organization. The Global MDR-TB and XDR-TB Response Plan, 2007–2008. WHO/HTM/TB/2007.387. World Health Organization, Geneva, Switzerland (2007).
- Zignol M, Hosseini MS, Wright A et al. Global incidence of multidrug-resistant tuberculosis. J. Infect. Dis.194(4), 479–485 (2006).
- Migliori GB, Matteelli A, Cirillo D, Pai M. Diagnosis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current standards and challenges. Can. J. Infect. Dis. Med. Microbiol.19(2), 169–172 (2008).
- Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part 2. Active tuberculosis and drug resistance. Expert Rev. Mol. Diagn.6(3), 423–432 (2006).
- Migliori GB, Loddenkemper R, Blasi F, Raviglione MC. 125 years after Robert Koch’s discovery of the tubercle bacillus: the new XDR-TB threat. Is “science” enough to tackle the epidemic? Eur. Respir. J.29(3), 423–427 (2007).
- Perkins MD, Cunningham J. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J. Infect. Dis.196(Suppl. 1), S15–S27 (2007).
- Morgan M, Kalantri S, Flores L, Pai M. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect. Dis.5, 62 (2005).
- Ling DI, Zwerling A, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur. Respir. J. DOI 10.1183/09031936.00061808 (2008) (Epub ahead of print).
- Barnard M, Albert H, Coetzee G, O’Brien R, Bosman ME. Rapid molecular screening for MDR TB in a high volume public health laboratory in South Africa. Am. J. Respir. Crit. Care Med. (2008).
- Kim SJ. Drug-susceptibility testing in tuberculosis: methods and reliability of results. Eur. Respir. J.25(3), 564–569 (2005).
- Pai M, Ramsay A, O’Brien R. Evidence-based tuberculosis diagnosis. PLoS Med.5(7), e156 (2008).
Websites
- World Health Organization. Policy statement. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB). World Health Organization, Geneva, Switzerland, 2008 www.who.int/tb/features_archive/policy_statement.pdf
- World Health Organization. Rapid tests for drug-resistant TB to be available in developing countries. World Health Organization, Geneva, Switzerland, 2008 www.who.int/tb/features_archive/mdrtb_rapid_tests/en/index.html